Market Cap 1.20B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 2,871,800
Avg Vol 5,401,370
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 24%
Beta 0.70
Analysts Strong Sell
Price Target $9.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Nov. 13 at 12:05 PM
0 · Reply
tranq19
tranq19 Nov. 13 at 11:54 AM
$ABCL sometime before your end so only a matter of weeks we should find out what their third candidate is, which they’ve been keeping under wraps for strategic reasons… 
0 · Reply
Bgggggggie
Bgggggggie Nov. 13 at 11:23 AM
$ABCL help me out, huge cash burn and nothing even close to market. Why are people bullish?
1 · Reply
RagingToro
RagingToro Nov. 13 at 2:55 AM
$ABCL cooking?
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 9:38 PM
$ABCL is a very good buy here... I sold my position and waited for this opportunity to reenter. Iam glad it gave me the opportunity to do so.... Its the perfect time to add to your position...
0 · Reply
Cassek86
Cassek86 Nov. 12 at 7:27 PM
$ABCL Holding strong in this market today.
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 6:18 PM
$ABCL IS COILING HERE FOR ANOTHER LEG UP...
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 5:26 PM
$ABCL adding more here..
0 · Reply
Samb2344
Samb2344 Nov. 12 at 5:08 PM
$ABCL aka stay buying $4 below crew
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 12 at 5:06 PM
💎 LiquidTheta® Live Actionable Trade Asset: $ABCL Contracts: $ABCL January 15, 2027 $5 Calls Scale in: $1.49- $1.83 Scale out: $5.81-$9.96 Profit Potential : 347% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Latest News on ABCL
AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 days ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 5 weeks ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 2 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 6 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 6 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 9 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 11 months ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results


Stocktradesmoon
Stocktradesmoon Nov. 13 at 12:05 PM
0 · Reply
tranq19
tranq19 Nov. 13 at 11:54 AM
$ABCL sometime before your end so only a matter of weeks we should find out what their third candidate is, which they’ve been keeping under wraps for strategic reasons… 
0 · Reply
Bgggggggie
Bgggggggie Nov. 13 at 11:23 AM
$ABCL help me out, huge cash burn and nothing even close to market. Why are people bullish?
1 · Reply
RagingToro
RagingToro Nov. 13 at 2:55 AM
$ABCL cooking?
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 9:38 PM
$ABCL is a very good buy here... I sold my position and waited for this opportunity to reenter. Iam glad it gave me the opportunity to do so.... Its the perfect time to add to your position...
0 · Reply
Cassek86
Cassek86 Nov. 12 at 7:27 PM
$ABCL Holding strong in this market today.
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 6:18 PM
$ABCL IS COILING HERE FOR ANOTHER LEG UP...
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 5:26 PM
$ABCL adding more here..
0 · Reply
Samb2344
Samb2344 Nov. 12 at 5:08 PM
$ABCL aka stay buying $4 below crew
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 12 at 5:06 PM
💎 LiquidTheta® Live Actionable Trade Asset: $ABCL Contracts: $ABCL January 15, 2027 $5 Calls Scale in: $1.49- $1.83 Scale out: $5.81-$9.96 Profit Potential : 347% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 3:47 PM
$ABCL DOWN ON NO VOLUME IS BULLISH NOT BEARISH....
0 · Reply
estatebuyersmia
estatebuyersmia Nov. 12 at 3:44 PM
$ABCL adding more under 4...
0 · Reply
Ed_Ng
Ed_Ng Nov. 12 at 3:40 PM
$ABCL it's over
1 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 1:12 PM
$ABCL $ABCL Looks like it wants to pop hard. This is a stock can EASILY see $15 if a couple big orders get squeezed. Be careful Shorts.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 12 at 12:33 PM
Enter: $ABCL Calls Strike Price: $4 Expiry Date: DEC 19 2025 Buy in Price: $0.55 - $0.60 Sell Price: $0.83 Profit : +51% (Turn every $1 into $1.51) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 7:36 AM
$ABCL Market makers simply pushed stocks lower today while you capitulated just in time! 😊 The government reopens tomorrow. Weird timing, right? 😜
0 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 6:18 AM
$ABCL GOOD NEWS! THE SHAKE OUT IS OVER THE GOVERNMENT REOPENS TONIGHT THE BIGGEST PUMP IN HISTORY STARTS AFTER THE MARKET CLOSES YOU'VE BEEN WARNED
0 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 5:10 AM
0 · Reply
Plutten1973
Plutten1973 Nov. 12 at 5:07 AM
$ABCL more than 27% shorted
0 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 2:30 AM
$ABCL $ABCL The capabilities of all companies are focused on quickly and effectively producing large quantities of antibodies. Stephen Quake's current interest is in AI virtual cells (Virtual Cell), which involve creating a universal representation based on cellular information (such as DNA, RNA, protein expression levels, etc.) and using that as a foundation for
0 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 1:40 AM
$ABCL Huge difference between normal biotech startups and AbCellera. $ABCL significantly derisks themselves by their business model. Not saying there’s no risk, but lots of stones in the fire on this one, with a nice cash runway.
1 · Reply
Stocktradesmoon
Stocktradesmoon Nov. 12 at 1:36 AM
$ABCL The problem with most biotechs is that their business model is not built with a contingency plan to carry the company if their blockbuster drug fails- hence why so many biotechs fail. $ABCL does not have this problem.
0 · Reply